GlassScriptPhysician profile
Martin Pico
NPI 1851853725
$3,358.13
in general payments reported to CMS, 2019-2025
9 companies · $1,866 in 2025
The $1,866 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,492 · 2025: $1,866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,814 · Travel and Lodging: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,814.39 |
| Travel and Lodging | $543.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,406.86 | 2024-2025 | Inceptiv, Intellis Adaptivestim, Accurian |
| Boston Scientific Corporation | $475.31 | 2025 | Intracept, Wavewriter Alpha Prime 16 |
| Biotronik Nro, INC. | $366.74 | 2024-2025 | Prospera |
| Saluda Medical Americas, INC. | $346.83 | 2024 | Evoke |
| Averitas Pharma INC. | $296.68 | 2024 | Qutenza |
| Nevro Corp. | $223.30 | 2024 | Senza |
| Globus Medical, INC. | $123.36 | 2025 | Senza |
| Curonix LLC | $90.60 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $28.45 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Pico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.